The Systems Virology lab at Laboratory Medicine focuses on using systems biology and experimental approaches to understand the biology of host-pathogen interactions targeted towards the RNA viruses. The group aims to identify the components of the immune response that are required for natural immune protection and disease severity that can be translated into the future development of vaccine and antiviral strategies against emerging and re-emerging viruses.
Our projects investigate immuno-metabolic reprogramming during viral infections, focusing on how viruses hijack host metabolism to facilitate replication and development of host-directed therapy. Using multi-omics systems biology, metabolic modeling, and experimental assays, we aim to identify key metabolic and signaling alterations induced by viral infections.
We aim to understand common global interferon-stimulated gene (ISG) responses against different viruses can provide a novel avenue for viral antagonism.
Lead: Soham Gupta.
We investigate how liver X receptors (LXRs) and estrogen receptor beta (ERβ) regulate immune responses, cholesterol metabolism, and cellular differentiation, with a particular focus on their roles in neurodegeneration.
Lead: Mukesh Varshney
We study the innate immune system in acute and chronic inflammatory diseases in children and adults.
Lead: Magdalini Lourda.
The Systems Infection Biology (CSIB) facility provides services for advanced bioinformatics analysis on transcriptomics, proteomics (targeted and untargeted), metabolomics (targeted and untargeted), microbiome (16s and metagenome), integrative multi-omics analysis including single cell analysis.
Facility Director: Anoop T. Ambikan
Photo: Getty ImagesA recent study published by researchers from Karolinska Institutet in collaboration with Sivas Cumhuriyet University, Turkey, sheds light on the connection between Crimean-Congo Haemorrhagic Fever Virus (CCHFV) infection and prolonged fatigue.
Photo: N/AThe Foundation for Strategic Research (SSF) has appointed Assistant Professor Bjørt Katrinardóttir Kragesteen at the Department of Medical Biochemistry and Biophysics as one of this year's Research Leaders of the Future.
Photo: Adobe StockA new study reveals that a significant proportion of people living with HIV (PWH) on long-term antiretroviral therapy remain at risk of immune and metabolic complications despite successful viral suppression. The findings highlight a pressing need for precision medicine approaches to improve long-term health outcomes for PWH.
